These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 11278163)

  • 1. Conformational properties of serine proteinase inhibitors (serpins) confer multiple pathophysiological roles.
    Janciauskiene S
    Biochim Biophys Acta; 2001 Mar; 1535(3):221-35. PubMed ID: 11278163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of Lys335 in the metastability and function of inhibitory serpins.
    Im H; Yu MH
    Protein Sci; 2000 May; 9(5):934-41. PubMed ID: 10850803
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the plasma elimination kinetics and conformational stabilities of native, proteinase-complexed, and reactive site cleaved serpins: comparison of alpha 1-proteinase inhibitor, alpha 1-antichymotrypsin, antithrombin III, alpha 2-antiplasmin, angiotensinogen, and ovalbumin.
    Mast AE; Enghild JJ; Pizzo SV; Salvesen G
    Biochemistry; 1991 Feb; 30(6):1723-30. PubMed ID: 1704258
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An overview of the serpin superfamily.
    Law RH; Zhang Q; McGowan S; Buckle AM; Silverman GA; Wong W; Rosado CJ; Langendorf CG; Pike RN; Bird PI; Whisstock JC
    Genome Biol; 2006; 7(5):216. PubMed ID: 16737556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tip of another iceberg: Drosophila serpins.
    Reichhart JM
    Trends Cell Biol; 2005 Dec; 15(12):659-65. PubMed ID: 16260136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The native metastability and misfolding of serine protease inhibitors.
    Cho YL; Chae YK; Jung CH; Kim MJ; Na YR; Kim YH; Kang SJ; Im H
    Protein Pept Lett; 2005 Jul; 12(5):477-81. PubMed ID: 16029161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What do dysfunctional serpins tell us about molecular mobility and disease?
    Stein PE; Carrell RW
    Nat Struct Biol; 1995 Feb; 2(2):96-113. PubMed ID: 7749926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Secondary structure changes stabilize the reactive-centre cleaved form of SERPINs. A study by 1H nuclear magnetic resonance and Fourier transform infrared spectroscopy.
    Perkins SJ; Smith KF; Nealis AS; Haris PI; Chapman D; Bauer CJ; Harrison RA
    J Mol Biol; 1992 Dec; 228(4):1235-54. PubMed ID: 1335516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for serpin inhibitor activity.
    Wright HT; Scarsdale JN
    Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Engineering thermostability in serine protease inhibitors.
    Im H; Ryu MJ; Yu MH
    Protein Eng Des Sel; 2004 Apr; 17(4):325-31. PubMed ID: 15126675
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of conformational change in serpin structure and function.
    Gettins P; Patston PA; Schapira M
    Bioessays; 1993 Jul; 15(7):461-7. PubMed ID: 8379949
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibitory serpins. New insights into their folding, polymerization, regulation and clearance.
    Gettins PG; Olson ST
    Biochem J; 2016 Aug; 473(15):2273-93. PubMed ID: 27470592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osmolytes as modulators of conformational changes in serpins.
    Chow MK; Devlin GL; Bottomley SP
    Biol Chem; 2001 Nov; 382(11):1593-9. PubMed ID: 11767949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High resolution structure of cleaved Serpin 42 Da from Drosophila melanogaster.
    Ellisdon AM; Zhang Q; Henstridge MA; Johnson TK; Warr CG; Law RH; Whisstock JC
    BMC Struct Biol; 2014 Apr; 14():14. PubMed ID: 24758516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of serpins in vertebrate immunity.
    Mangan MS; Kaiserman D; Bird PI
    Tissue Antigens; 2008 Jul; 72(1):1-10. PubMed ID: 18498291
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding the specificity of serpin-protease complexes through interface analysis.
    Rashid Q; Kapil C; Singh P; Kumari V; Jairajpuri MA
    J Biomol Struct Dyn; 2015; 33(6):1352-62. PubMed ID: 25052369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serpins for diagnosis and therapy in cancer.
    Zheng D; Chen H; Davids J; Bryant M; Lucas A
    Cardiovasc Hematol Disord Drug Targets; 2013 Aug; 13(2):123-32. PubMed ID: 23988000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Viscous drag as the source of active site perturbation during protease translocation: insights into how inhibitory processes are controlled by serpin metastability.
    Shin JS; Yu MH
    J Mol Biol; 2006 Jun; 359(2):378-89. PubMed ID: 16626735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serpins and other covalent protease inhibitors.
    Ye S; Goldsmith EJ
    Curr Opin Struct Biol; 2001 Dec; 11(6):740-5. PubMed ID: 11751056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of a serpin-protease complex shows inhibition by deformation.
    Huntington JA; Read RJ; Carrell RW
    Nature; 2000 Oct; 407(6806):923-6. PubMed ID: 11057674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.